Abstract
We designed the present study to investigate differences in prognostic factors and failure patterns between patients with invasive micropapillary carcinoma or carcinoma with micropapillary component (IMPC) and randomly matched patients with invasive ductal carcinoma (IDC) of the breast at multiple institutions of the Korean Radiation Oncology Group (KROG). This retrospective multicenter study was performed using subjects treated from January 1999 to November 2011. Female patients who had undergone curative resection for breast cancer without neoadjuvant chemotherapy were considered for this study. Exact matches were made for age (± 3 years), pathologic tumor and node stage, treatment method (surgery with or without radiotherapy), and period when surgery was performed (within 1 year) at the same institution. A total of 534 patients were analyzed. The median follow-up period was 59 months in both groups. In the comparison of clinicopathologic characteristics, rates of lymphovascular invasion (LVI) and nuclear grade III were both significantly higher in IMPC than in IDC (P < .001, P = .01, respectively). During the follow-up period, recurrences developed in 40 patients with IMPC (15.0%) and 21 with IDC (7.9%). Locoregional recurre...Continue Reading
References
Jan 1, 1996·Pathology, Research and Practice·S Luna-MoréM A Cañadas
Feb 10, 2000·Human Pathology·M PaterakosA D Thor
Feb 16, 2000·Pathology, Research and Practice·S Luna-MoréI Gornemann
Mar 19, 2002·The Breast Journal·Meena S Moran, Bruce G Haffty
Aug 30, 2003·Oncogene·Bruce G Haffty, Peter M Glazer
Jun 17, 2004·American Journal of Clinical Pathology·Guido PettinatoGiuseppe Petrella
Aug 15, 2006·International Journal of Radiation Oncology, Biology, Physics·Coen W HurkmansJorien Cassee
Apr 18, 2008·International Journal of Surgical Pathology·Ling ChenLi Fu
May 20, 2008·The Journal of Pathology·C MarchiòJ S Reis-Filho
Nov 7, 2008·The American Journal of Surgical Pathology·Geza AcsPaul J Zhang
May 13, 2009·Annals of Diagnostic Pathology·Isabel Alvarado-CabreroErika Ruíz
Mar 23, 2010·The Breast : Official Journal of the European Society of Mastology·Jeong Il YuSuk Jin Nam
May 7, 2010·Japanese Journal of Clinical Oncology·Rin YamaguchiHirohisa Yano
Jun 29, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A GoldhirschUNKNOWN Panel members
Dec 8, 2011·Breast Cancer Research and Treatment·Aoife J LoweryKarl J Sweeney
Oct 4, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G von Minckwitz, M Martin
Dec 19, 2012·Clinical Breast Cancer·Albert C ChenBin S Teh
Jun 26, 2013·Oncology·Jeong Il YuSeung Jae Huh
Oct 19, 2013·Radiation Oncology Journal·Yuri JeongSeung Do Ahn
Jan 8, 2014·The Journal of Pathology·Rachael NatrajanJorge S Reis-Filho
Feb 22, 2014·Breast Cancer Research and Treatment·Fausto PetrelliSandro Barni
Jun 13, 2014·British Journal of Cancer·A C ChenB S Teh
Citations
Jul 30, 2016·Archives of Pathology & Laboratory Medicine·Yi-Ling YangLi Fu
Aug 6, 2016·World Journal of Surgical Oncology·Guanqiao LiChangsheng Ye
Oct 27, 2017·Cancer Medicine·Hongliang ChenPeng Zhang
Dec 13, 2017·BMC Cancer·Yun WuQifeng Yang
Feb 7, 2018·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Weidong LiLi Fu
Oct 23, 2019·Cancer Communications·Gary D LewisBin S Teh
Apr 19, 2017·Oncotarget·Shen-Li TangQing Lv
Jul 20, 2019·The Breast Journal·Gary D LewisBin S Teh
Aug 3, 2018·Breast Care·Jamila ShujaKhushnaseeb Ahmad
Mar 23, 2019·Acta Radiologica·Ga Young YoonWoo Jung Choi
Sep 14, 2020·Breast Cancer Research and Treatment·Frederik DemanGiuseppe Floris
Aug 6, 2020·OncoTargets and Therapy·Le ZhangLu Tang
Jan 9, 2021·Clinical Breast Cancer·Xiangdi MengQingyong Xu
Dec 18, 2020·Medicine·Xin GuanYi Dong
Oct 27, 2015·Rare Tumors·UNKNOWN Rare Cancer Network